FINAL DIAGNOSIS:

UUID : 32481AD7-2C27-4GBC-81AF-FBS3FF84D325
Redacted

iiii|iil||IlIlIIiIIIIiIIiIIlIIIIIIIiIiIIIiiiiiiliiiiiiiliiiiiiiiiii
covecionoare: Ill II||l|l|l|||||||l|l||||||||||||I||||I||||||||||||||||Il|
IIIIiiIiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiliiiiiiii

PART‘I: CONTENTS. CENTRAL COMPARTMENT, EXCISION —

A. SIX OF SIX LYMPH NODES POSITIVE FOR METASTATIC PAPILLARY THYROID CARCINOMA (616).

B. PARATHYROID PROFILE (I).

, PART 2: ' THYROID. TOTAL THYROIDECTOMY -

PFNPPP?‘

PAPILLARY THYROID CARCINOMA, FOLIJCULAR VARIANT, OF LEFT LOSE, 2.6 CM.
CARCINOMA INVADES PERI-THYROIDAL SOFT TISSUE.

CARCINOMA FOCALLY INVOLVES THE SKELETAL MUSCLE.

LYMPHOVASCULAR INVASION IDENTIFIED.

CARCINOMA EXTENSIVELY PRESENT AT THE PERIPHERAL SURGICAL MARGINS.
ONE CENTRAL LYMPHN NODE, POSITIVE FOR METASTATIC PAPILLARY THYROID CARCINOMA (1/1).

TNM STAGE (AJCC, 7th Edition): [3 13 m

PART 3: PARATHYROID, LEFT SURERIOR, BIOPSY «-
NORMOCELLULAR PARATHYROID TISSUE, 20 MILLIGRAMS.

COMMENT:

Selected slides of part 2 of this case are 3

CASE SYNOPSIS:

leo reviewed by Dr.

who agrees with the diagnosis.

SYNOPTIC DATA - PRIMARY THYROID TUMORS

SPECIMEN TYPE: Total Thyroidectomy
TUMOR SITE: Leﬂ Lobe
TUMOR FOCALITY: Unifocai
TUMOR SIZE (largest nodule): Greatest Dimension: 2.8 cm
I Additional Dimensions: 2.0 cm
HISTOLOGIC TYPE": Papillary carcinoma
PRIMARY TUMOR (pT): pT3
REGIONAL LYMPH NODES (pN): lea

Number of regional lymph nodes examined: 7
Number of regional lymph nodes involved: 7

EXTRANODAL EXTENSION: Not identiﬁed

DISTANT METASTASIS (pM): Not applicable
EXTRATHYROIDAL EXTENSION: Present

MARGINS: Margin(e) involved by carcinoma
LYMPl-l-VASCUIAR INVASION: Present

ADDITIONAL PATHOLOGIC FINDINGS: None Identiﬁed

ADDEN DA:
Addendum

This addendum is to clarify the diagnosis in part 2 of this case.
The first line of the diagnosis should read: PAPILLARY THYROID CARCINOMA. OF LEFT LOBE, 2.6 CM.

 

“Lb—(VB .
CW4, Pﬁ—IFII‘WK WWI“ Iliad/5
3H.“ Ww’maﬁ C7333

    
  
   
      
    
 

Criteri-
Diagnosis Discrepancy
anary Tumor Size Discrepancy
)hIPAA‘DI‘saepincy ‘—
Srlar Maiignancy History
, ual/Synrhronous Primary N
fig: is (:irue): “

Roviewerlniliai: [so / E'SGUAUHED

D [9 Review“.

  

